The identification of mutations that underlie rare diseases has dramatically accelerated in recent years thanks to next-generation sequencing. This Review discusses strategies for further identification studies, insights into disease mechanisms and the clinical implications of the rapid progress in this field of research.
- Kym M. Boycott
- Megan R. Vanstone
- Alex E. MacKenzie
